Karus Therapeutics interviewed by Pharma Television

Oxford, UK, 17 July 2013 – Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, was interviewed about its pioneering work in the HDAC and PI3K arena. Dr Simon Kerry, Karus’s CEO discussed the Company’s plans to develop current programmes using its substantial financing backing with Pharma Television’s Fintan Walton at the 10th Anglonordic Biotech Conference, London, UK. To watch the interview, please follow the link here.